Clinical Trials Directory

Trials / Completed

CompletedNCT05503212

Best Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral Artery Occlusions

Best Revascularisation Approach for Posterior Circulation Strokes With Isolated Vertebral : the BRAVO Retrospective Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
682 (actual)
Sponsor
Centre Hospitalier Universitaire Vaudois · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Isolated vertebral artery occlusions (VAO) account for approximately one third of posterior circulation occlusions, but have been given the least attention among posterior circulation strokes. If the two recent ATTENTION and BAOCHE randomized clinical trials have proven the superiority of endovascular thrombectomy (EVT) in basilar artery occlusions, data on the effectiveness and harm of acute revascularization treatment on isolated VAO is scarce. We aim to investigate the impact of acute recanalisation treatments in acute ischemic stroke patients with isolated VAO. In the absence of RCT, observational data with appropriate statistical methods may give indications on benefits and harms of treating neglected stroke situations like acute vertebral occlusion. Results may also lay the basis for prospective studies, such as randomized clinical trials.

Conditions

Interventions

TypeNameDescription
OTHERConservative treatment (CT)Best medical treatment without intravenous thrombolysis nor endovascular thrombectomy
OTHERIntravenous thrombolysis (IVT)Best medical treatment with intravenous thrombolysis but without endovascular thrombectomy
OTHEREndovascular thrombectomy (EVT) ± intravenous thrombolysis (IVT)Best medical treatment with endovascular thrombectomy with or without intravenous thrombolysis

Timeline

Start date
2003-01-01
Primary completion
2023-08-09
Completion
2023-08-09
First posted
2022-08-16
Last updated
2023-08-14

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05503212. Inclusion in this directory is not an endorsement.